Back to search

Article

Nanoparticles Delivering Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Prevent Osteoporosis by Increasing Bone Formation

2021-09-20

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Promoting bone marrow mesenchymal stem cell (BMSC) osteoblastic differentiation is a promising therapeutic strategy for osteoporosis (OP). The present study demonstrates that miR-483-5p inhibits the osteogenic differentiation of BMSCs. Therefore, selectively delivering the nanoparticles carrying antagomir-483-5p (miR-483-5p inhibitor) to BMSCs is expected to beco...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5aa8e486-2bc9-52af-9425-0ef679d1a69e
DOI
10.21203/rs.3.rs-882695/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Nanoparticles Delivering Antagomir-483-5p to Bone Marrow Mesenchymal Stem Cells Prevent Osteoporosis by Increasing Bone FormationDOI 10.21203/rs.3.rs-882695/v1
Select a neighboring publication to make it the new centre.